NPS Pharmaceuticals, Inc. Reports Second Quarter 2010 Financial Results and Two Phase 3 Registration Programs on Track with Stated Timelines

August 5, 2010 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, a specialty pharmaceutical company developing innovative therapeutics for rare gastrointestinal and endocrine disorders, today reported its results for the second quarter 2010.

Twitter
LinkedIn
Facebook
Email
Print

Earnings